ARB-treated women have higher risk of new-onset diabetes

04/22/2012 | Diabetes.co.uk (U.K.)

Hypertensive women who were prescribed angotensin receptor blockers were 93% more likely to develop new-onset diabetes compared with those who received angiotensin-converting-enzyme inhibitors, a study in the Journal of Clinical Hypertension revealed. More study is needed but the findings may aid in decision-making among clinicians, the lead researcher said.

View Full Article in:

Diabetes.co.uk (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC